NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Synucleinopathies comprise three distinct disorders: Parkinson's disease, Lewy body dementia and multiple system atrophy, all of which involve the pathological aggregation of a protein called alpha-synuclein (α-syn). In order to establish an accurate diagnosis of these disorders, and thus improve patient care or inclusion in therapeutic trials, methods based on the in vitro amplification of pathological α-syn have been developed. In this review, we will discuss the history and development of these techniques, their strengths, and the promising prospects they offer for early patient screening using a simple blood sample.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.